Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, November 19, 2012

Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells



Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells

Highlights

► Navitoclax and other BH3 mimetics have previously shown synergy with chemotherapeutic agents
► Where antagonism between carboplatin and/or paclitaxel was observed, this was reduced by the inclusion of navitoclax.
► Navitoclax improves the activity of carboplatin and/or paclitaxel in Igrov-1 spheroids.

0 comments :

Post a Comment

Your comments?